30/04/2025 17:38
|
Biotechnology
Sydney, Australia – 30 April 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) (“OncoSil” or “the Company”) is pleased to announce that the Federal Joint Committee...